China Molybdenum Co Ltd
OTC:CMCLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Molybdenum Co Ltd
OTC:CMCLF
|
CN |
|
Fukuoka Financial Group Inc
OTC:FKKFY
|
JP |
|
Be Shaping the Future SpA
F:DAF
|
IT |
|
Cellnex Telecom SA
MAD:CLNX
|
ES |
|
Shenzhen United Winners Laser Co Ltd
SSE:688518
|
CN |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
Bufab AB (publ)
STO:BUFAB
|
SE |
|
MLP Saglik Hizmetleri AS
IST:MPARK.E
|
TR |
|
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CMCLF's stock price target?
Not Available
CMCLF doesn't have any price targets made by Wall Street professionals.
What is China Molybdenum Co Ltd's Revenue forecast?
Projected CAGR
4%
For the last 13 years the compound annual growth rate for China Molybdenum Co Ltd's revenue is 31%. The projected CAGR for the next 3 years is 4%.
What is China Molybdenum Co Ltd's Operating Income forecast?
Projected CAGR
25%
For the last 13 years the compound annual growth rate for China Molybdenum Co Ltd's operating income is 25%. The projected CAGR for the next 3 years is 25%.
What is China Molybdenum Co Ltd's Net Income forecast?
Projected CAGR
30%
For the last 13 years the compound annual growth rate for China Molybdenum Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 30%.
